DCTH Delcath Systems Sotuvning sof marjinal rentabelligi

Delcath Systems Inc (DCTH) tovar belgisi

Delcath Systems, Inc. (DCTH) onkologiya markazlari bilan hamkorlik qiladi va jigar metastazlari uchun noyob perfuziya terapiyasini taklif etadi. GURU.Markets platformasida samarali savdo marjalarini tahlil qilish biznesning barqarorligini ochib beradi, bunda 6.00 ko'rsatkichning joriy qiymatini aks ettiradi. Daromadlilik xodimlarning sonini ko'paytirmasdan sarflanadigan materiallar savdosi hisobiga ta'minlanadi, Hepzato Kit ning patent himoyasi esa yangi ishtirokchilar uchun kirishning sezilarli to'siqlarini yaratadi.

DCTH: Delcath Corp Kompaniyaning sof rentabelligi 04.07.2022 - 19.11.2026

Delcath Corp (DCTH) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning barcha koʻrsatkichlari tahlili:Delcath Corp, DCTH
Delcath tayyor mahsulotlari

Yuqori texnologiyali avtomatlashtirilgan ximioterapiya dozalash tizimlarini joriy etuvchi Delcath Systems, Inc. (DCTH) uchun operatsion xarajatlar qarshisida foydaning barqarorligi uning innovatsiyalarining bozorga mosligi darajasini belgilaydi. Sof foyda marjasini tahlil qilish orqali investor jami daromadning sof foyda ulushini baholaydi, bu esa vaqtincha pasayishlarni tizimli biznes degradatsiyasidan farqlash hamda kapitalning muzlab qolish xavfini minimallashtiruvchi kirish nuqtasini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|YmAbs - Kompaniyaning sof rentabelligi|aurabiosciences.com (AURA) - Sof marja|Candel Therapeutics Inc. - Sof foyda normasi|Sof marja Accuray Inc.|Sof marja SELLAS Life Sciences Group SLS|Sotuvning sof marjinal rentabelligi ACTU|CTOR - Sof marja|Sotuvning sof marjinal rentabelligi HURA (TuHURA Biosciences, Inc.)|Sof foyda normasi TARA|FATE: Sof foyda bo'yicha sotuv rentabelligi|WHWK (aadibio.com) - Sotuvning sof rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)